Evidence map›Paper›PMID 30730024›Full record

ArticleMagma (New York, N.Y.)2019

Realization of

Mikhail V Gulyaev, Aleksandra V Kuznetsova, Denis N Silachev, Tatyana I Danilina, Lev L Gervits, Yury A Pirogov

Abstract read
PubMed Publisher
In one paragraph

Article in Magma (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Multinuclear MRI Research.Applied magnetic resonance · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mikhail V GulyaevM.V. Lomonosov Moscow State University, Moscow, 119991, Russia. mihon-epsilon@yandex.ru.
Aleksandra V KuznetsovaM.V. Lomonosov Moscow State University, Moscow, 119991, Russia.
Denis N SilachevM.V. Lomonosov Moscow State University, Moscow, 119991, Russia.
Tatyana I DanilinaM.V. Lomonosov Moscow State University, Moscow, 119991, Russia.
Lev L GervitsA.N. Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Moscow, 119991, Russia.
Yury A PirogovM.V. Lomonosov Moscow State University, Moscow, 119991, Russia.

Funding

Russian Foundation for Basic Research 17-02-00465
6 · The paper itself

Abstract

objectiveTo identify the technical aspects of the potential use of clinically approved perfluorodecalin (PFD, C MATERIALS AND

methods

resultsThe selective excitation of the magnetically equivalent

conclusionThe study showed the feasibility of the successful application of PFD for

Indexed as

AnimalsBrain NeoplasmsCell Line, TumorFluorineFluorocarbonsGliomaIsotopesMagnetic FieldsMagnetic Resonance ImagingMaleOximetryOxygenPhantoms, ImagingRatsRats, WistarFluorineFluorocarbonsIsotopesOxygenperfluorodecalin19F MRI oximetry methodC6 rat brain gliomaPerfluorodecalinRARE-VTR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.